EVFM News and Press, Evofem Biosciences Inc. From 09/11/23

Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor PR Newswire -- Investor withdraws March 2023 Notice of Default -- -- Notes are no longer convertible to shares of common stock, removing potential dilution from the previously...

Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange PR Newswire SAN DIEGO , Aug. 22, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced it has signed a confiden...

Evofem to Participate in the Virtual Investor Summer Spotlight Series PR Newswire -- Live moderated video webcast with members of Evofem management team on Wednesday, July 12 th at 4:00 p.m. ET -- SAN DIEGO , July 6, 2023 /PRNewswire/ -- Evo...

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire Increased net product revenue more than 35% in the first quarter of 2023 vs. prior year quarter Reduced operating expenses more than 70% Decrease...

2023-05-17 17:23:44 ET Evofem Biosciences ( OTCQB:EVFM ) on Wednesday announced a 1-for-125 reverse stock split. The reverse stock split was approved by the company's shareholders at a special meeting held in mid-March. The company said its common stock will open for trading o...

Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change to "EVFMD" for 20 business days, then revert to "EVFM" -- SAN DIEGO , Ma...

2023-04-28 07:23:38 ET Evofem Biosciences press release ( OTCQB:EVFM ): FY GAAP EPS of -$1.34. Revenue of $16.84M (+104.4% Y/Y). For further details see: Evofem Biosciences GAAP EPS of -$1.34, revenue of $16.84M

Evofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update PR Newswire -- Net product sales more than doubled in 2022 vs. prior year -- -- Reduced total operating expenses by $74.1 million in 2022 vs. 2021, exceeding stated goal --...

2023-04-14 09:28:17 ET Evofem Biosciences ( OTCQB:EVFM ) has announce d the appointment of Ivy Zhang as CFO and Secretary, effective April 13, 2023. Reporting to CEO Saundra Pelletier, Ms. Zhang will lead Evofem's finance organization and financial activities. ...

Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary PR Newswire SAN DIEGO , April 14, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. , (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced ...